Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Meeting Updates
Further to our outcome of Board Meeting held on June 05, 2020 we are enclosing signed Audited Financial Results for the Quarter and Year ended March 31, 2020 along with Statement of Assets and Liabilities, Cash Flow statement & Audit Report for the year ended March 31, 2020. Lasa Supergenerics Ltd - 540702 - Clarification
With reference to last announcement disseminated on exchange website w r t Intimation of Board Meeting of Amarnath Securities Ltd you are requested to ignore the same as it is uploaded inadvertently Lasa Supergenerics Ltd - 540702 - Clarification
With reference to last announcement disseminated on exchange website w r t Intimation of Board Meeting of Amarnath Securities Ltd you are requested to ignore the same as it is uploaded inadvertently Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Meeting Updates
Intimation about the Board Meeting and Closure of Trading Window Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
LASA SUPERGENERICS Q4 PAT AT 2.58CRS, UP 243.33% YOY Lasa Supergenerics Ltd - 540702 - Financials Result For The Year Ended March 31,2020
Pursuant to Regulation 33 of the SEBI (Listing?Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Statement of Audited Financial Results for the quarter and year ended March 31, 2020 along with statement of Assets & Liabilities, Cash Flow Statements and Auditors Report submitted by the Statutory Auditors of the Company. Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E Friday June 05, 2020
we write to inform you that Board of Directors at their meeting held today through video conferencing which was commenced at 12.00 p.m. and concluded at 2.00 pm. has considered, approved and took on record the Audited Financial Results for the Quarter and Year ended March 31, 2020 along with Statement of Assets and Liabilities & Audit Report for the year ended March 31,2020. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Intimation For Board Meeting Scheduled To Be Held On Friday June 05, 2020 At 12.00 P.M. (IST)
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2020 ,inter alia, to consider and approve Inter-alia, to consider, approve and take on record Audited Financial Results along with the Auditor Report of the Company for the quarter and year ended March 31, 2020, and/or to discuss any other business/matter with the permission of the Chair Lasa Supergenerics Ltd - 540702 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015
This is to certify that in compliance with regulation 7(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, all activities in relation to share transfer facility are maintained by our Share Transfer Agent i.e. Bigshare Services Private Limited having permanent SEBI Registration No INR0000001385.